Technology ❯ Biotechnology

Gene Therapy

Hearing Restoration CRISPR Applications CRISPR Clinical Trials In Vivo Editing Ex Vivo Therapies Mitochondrial Replacement Therapy Regenerative Medicine Optogenetic Techniques CRISPR Technology Genome Editing Technologies Transcription Factors Viral Vectors Mitochondrial Therapy Medical Innovations mRNA Technology Adeno-Associated Virus Genome Editing Cell Engineering Gene Silencing Protein Synthesis Lipid Nanoparticles Cell Therapy Huntington's Disease Genetic Research Regulatory Pathways Genome Editing Techniques CRISPR Systems CAR-T Therapy Medical Devices Non-Viral Delivery Organ Bioprinting ASO Technology Manufacturing Processes

Lilly Acquires Engage Biologics for Up to $202 Million

The deal gives Lilly a preclinical Tethosome non‑viral DNA delivery platform, a lipid‑nanoparticle approach designed to target potency, tolerability and re‑dosing limits in DNA therapies.

Aurora Therapeutics Launches to Scale Bespoke Gene Editing for PKU

Prime Editing Tool PERT Debuts as Broad, One-Time Strategy for Nonsense Mutations

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

mRNA-Style Antiviral Mimics Rare Mutation to Block Viruses for Days in Rodents

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion